1227068-67-8 Usage
General Description
1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridin-1(2h)-yl)ethanone is a highly specific chemical compound mainly utilized in the field of synthetic chemistry. It contains several structural components, including a dioxaborolane and dihydropyridine group. The presence of the tetramethyl dioxaborolane component often means this compound can be used in boron-aided chemical reactions such as the Suzuki reaction, a common method of forming carbon-carbon bonds. Given its detailed structure, the synthesis of this chemical tends to be complex and is generally used in specialized industrial or academic research contexts. Its exact properties such as corrosion, environmental impact, and potential health effects are dependent on the specific conditions of its synthesis and usage.
Check Digit Verification of cas no
The CAS Registry Mumber 1227068-67-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,7,0,6 and 8 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1227068-67:
(9*1)+(8*2)+(7*2)+(6*7)+(5*0)+(4*6)+(3*8)+(2*6)+(1*7)=148
148 % 10 = 8
So 1227068-67-8 is a valid CAS Registry Number.
InChI:InChI=1S/C13H22BNO3/c1-10(16)15-8-6-11(7-9-15)14-17-12(2,3)13(4,5)18-14/h6H,7-9H2,1-5H3
1227068-67-8Relevant articles and documents
TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS
-
, (2021/04/23)
Disclosed are a series of compounds or their tautomers having a general structure represented by Formula (la), (lb), (Ila), (lIb), or (lIc) and pharmaceutically acceptable salts thereof. The present disclosure also relates to pharmaceutical compositions comprising said compounds or tautomers. The present disclosure further relates to a method of treating a disease or condition associated with iron dysregulation or dysfunctional iron homeostasis comprising administering to a subject in need thereof a therapeutically effective amount of Formula (la), (lb), (Ila), (lIb), or (lIc) compounds or tautomers.
Substituted Indoles
-
Paragraph 0649, (2017/07/14)
The invention provides for compounds of formula (I) wherein R1, R2, R3, R4, R5, and R6 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, th
ISOCHROMENE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS
-
, (2015/06/24)
Compounds of formula (I) described herein are useful for inhibiting phosphoinositide 3-kinases (PI3K) and the treatment of disorders associated with PI3K enzymes.
